Peptides: A new class of anticancer drugs

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2009, Vol 63, Issue

Abstract

Peptides are a novel class of anticancer agents embracing two distinct categories: natural antibacterial peptides, which are preferentially bound by cancer cells, and chemically synthesized peptides, which bind specifically to precise molecular targets located on the surface of tumor cells. Antibacterial peptides bind to both cell and mitochondrial membranes. Some of these peptides attach to the cell membrane, resulting in its disorganization. Other antibacterial peptides penetrate cancer cells without causing cell membrane damage, but they disrupt mitochondrial membranes. Thanks to phage and aptamer libraries, it has become possible to obtain synthetic peptides blocking or activating some target proteins found in cancer cells as well as in cells forming the tumor environment. These synthetic peptides can feature anti-angiogenic properties, block enzymes indispensable for sustained tumor growth, and reduce tumor ability to metastasize. In this review the properties of peptides belonging to both categories are discussed and attempts of their application for therapeutic purposes are outlined.

Authors and Affiliations

Ryszard Smolarczyk, Tomasz Cichoń, Stanisław Szala

Keywords

Related Articles

Schwann cells in therapy of spinal cord injuries

Schwann cells (SC) have a special activity in the repair processes after injury of the nervous system because of the capability of differentiation, migration, proliferation and myelinization of axons. They enhance produc...

Characterization of an inflammatory response

The intensity of an inflammatory response in a tissue or an organ is dependent on the efficiency of the organism’s homeostatic mechanisms, which restrict the extent of the reaction. The type of factor inducing a inflamma...

Cancer stem cells

Cancer stem cell theory gains increasingly greater significance in the world of medicine. Numerous findings of scientific research in vivo and in vitro indicate that it is the population of undifferentiated, self-renewin...

Metyloprednizolon – ostre urazy rdzenia kręgowego, korzyści czy zagrożenia?

Metyloprednizolon to syntetyczny glikokortykosteroid o silnym i długotrwałym działaniu przeciwzapalnym, przeciwalergicznym oraz immunosupresyjnym. Mechanizm działania metyloprednizolonu jest wynikiem wielu zmian komórkow...

When defense becomes dangerous – transcription factor Nrf2 and cancer

The transcription factor Nrf2 controls the expression of genes encoding cytoprotective enzymes and proteins. Its activation is related to conformational changes in the inhibitory protein Keap1 and/or Nrf2 phosphorylation...

Download PDF file
  • EP ID EP66360
  • DOI -
  • Views 184
  • Downloads 0

How To Cite

Ryszard Smolarczyk, Tomasz Cichoń, Stanisław Szala (2009). Peptides: A new class of anticancer drugs. Advances in Hygiene and Experimental Medicine, 63(), 360-368. https://europub.co.uk/articles/-A-66360